Rchr
J-GLOBAL ID:202001020091833201   Update date: Sep. 20, 2024

Ogihara Takashi

オギハラ タカシ | Ogihara Takashi
Affiliation and department:
Job title: Pharmacist
Research field  (1): Clinical pharmacy
Research keywords  (3): Peripheral vascular impairment ,  Peripheral neuropathy ,  Pain
Research theme for competitive and other funds  (1):
  • 2020 - 2022 Elucidation of oxaliplatin-induced peripheral neuropathy focusing on peripheral blood flow / peripheral temperature regulation mechanism
Papers (12):
  • 冨田 猛, 木村 丈司, 山本 和宏, 宇田 篤史, 藤田 浩平, 荻原 孝史, 糸原 光太郎, 北廣 優実, 大村 友博, 矢野 育子. ニルマトレルビル/リトナビル併用時にタクロリムス濃度の異常高値を認めた腎移植症例. 日本医薬品情報学会総会・学術大会講演要旨集. 2023. 25回. 147-147
  • 藤田 浩平, 山本 和宏, 宇田 篤史, 荻原 孝史, 阪上 倫行, 田村 直暉, 木村 丈司, 糸原 光太郎, 北廣 優実, 大村 友博, et al. 高度腎機能低下患者におけるバンコマイシンAUC-guided TDMの安全性に関する検討. TDM研究. 2023. 40. 2. 176-176
  • Takashi Ogihara, Masato Kagawa, Rintarou Yamanaka, Satoshi Imai, Kotaro Itohara, Daiki Hira, Shunsaku Nakagawa, Atsushi Yonezawa, Michiho Ito, Takayuki Nakagawa, et al. Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis. Journal of Natural Medicines. 2022
  • Madoka Koyanagi, Satoshi Imai, Yuki Iwamitsu, Mayuna Matsumoto, Mamiko Saigo, Akari Moriya, Takashi Ogihara, Yui Nakazato, Atsushi Yonezawa, Shunsaku Nakagawa, et al. Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. Neuropharmacology. 2021. 188. 108514-108514
  • Madoka Koyanagi, Satoshi Imai, Mayuna Matsumoto, Yoko Iguma, Nobuko Kawaguchi-Sakita, Takeshi Kotake, Yuki Iwamitsu, Mpumelelo Ntogwa, Ren Hiraiwa, Kazuki Nagayasu, et al. Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy. Cancer research. 2021. 81. 8. 2207-2219
more...
MISC (2):
  • Ogihara Takashi, Hayashi Maho, Nakagawa Takayuki, Imai Satoshi, Matsubara Kazuo. Improvement by a phosphodiesterase type 5 inhibitor in the vascular impairment prevents oxaliplatin-induced peripheral neuropathy. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2019. 92. 0. 2-O-44
  • Koyanagi Madoka, Imai Satoshi, Matsumoto Mayuna, Iwamitsu Yuki, Ogihara Takashi, Hiraiwa Ren, Ntogwa Mpumelelo, Nakagawa Takayuki, Matsubara Kazuo. Schwann cell-dependent immune response is related to taxane-induced peripheral neuropathy. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2019. 92. 0. 1-YIA-15
Lectures and oral presentations  (5):
  • 5-フルオロウラシル誘発口内炎モデルハムスターに対する半夏瀉心湯軟膏の有効性の検討
    (日本薬学会第140年会)
  • オキサリプラチン誘発末梢神経障害モデルマウスにおける血管拡張薬の効果検討
    (第69回日本薬学会関西支部総会・大会)
  • PDE5阻害薬の末梢血流改善作用によるオキサリプラチン誘発末梢神障害の予防効果
    (第92回日本薬理学会年会)
  • Improvement of vascular impairment by tadalafil, a phosphodiesterase type 5 inhibitor, alleviates and prevents oxaliplatin-induced peripheral neuropathy in mice
    (The 17th World Congress on Pain 2018)
  • オキサリプラチン長期投与によって誘発される冷過敏応答に対する末梢血流障害改善による治療・予防効果
    (「温度生物学」第6回領域会議 ・第4回若手の会 2018)
Education (1):
  • 2016 - 2020 Kyoto University Graduate School of Pharmaceutical Sciences
Professional career (1):
  • 京都大学博士(薬学) (京都大学)
Work history (2):
  • 2022/04 - 現在 神戸大学医学部附属病院 薬剤部 薬剤師
  • 2020/04 - 2022/03 Kyoto University Graduate School of Pharmaceutical Sciences Program-Specific Assistant Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page